Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Common Equity (2009 - 2026)

Updated

Bristol Myers Squibb's Common Equity came in at $23.4 billion for Q3 2026, up 25.8% from $18.6 billion a year earlier and up 4.9% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Common Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb's Common Equity was $18.51 billion, up 12.9% from FY2024.

  • Common Equity carries a five-year compound annual growth rate of -13.3% (FY2020 to FY2025).
  • Going back by year, Common Equity was $16.39 billion in FY2024 (-44.4%), $29.49 billion in FY2023 (-5.2%), $31.12 billion in FY2022 (-13.6%) and $36.01 billion in FY2021 (-5.0%).
  • The Q3 2026 figure represents the highest quarterly Common Equity since Q4 2023.
  • Year-over-year, Common Equity has increased for seven consecutive quarters, with growth averaging 6.6% over the last eight quarters.
  • The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 27.6%), and the weakest in Q1 2024 (a decline of 48.1%).
  • Business Quant data shows BMY's Common Equity at $22.32 billion (Q2 2026), $20.1 billion (Q1 2026) and $18.51 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 81.53 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -4.58 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 51.81 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 13.04 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 89.30 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 23.40 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23.40 Bn
Jun 30, 2026 22.32 Bn
Mar 31, 2026 20.10 Bn
Dec 31, 2025 18.51 Bn
Sep 30, 2025 18.60 Bn
Jun 30, 2025 17.49 Bn
Mar 31, 2025 17.45 Bn
Dec 31, 2024 16.39 Bn
Sep 30, 2024 17.20 Bn
Jun 30, 2024 17.07 Bn
Mar 31, 2024 16.55 Bn
Dec 31, 2023 29.49 Bn
Sep 30, 2023 29.06 Bn
Jun 30, 2023 32.03 Bn
Mar 31, 2023 31.89 Bn
Dec 31, 2022 31.12 Bn
Sep 30, 2022 32.73 Bn
Jun 30, 2022 32.66 Bn
Mar 31, 2022 31.65 Bn
Dec 31, 2021 36.01 Bn
API Access

Bristol Myers Squibb Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=BMY&period=max&api_key=YOUR_API_KEY